Copyright Reports & Markets. All rights reserved.

Global Medical In-Vitro Toxicology Testing Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Market Analysis by Type
    • 1.3.1 Global Medical In-Vitro Toxicology Testing Market Size Growth Rate by Type: 2020 VS 2026
    • 1.3.2 Cell Culture Technology
    • 1.3.3 High Throughput Technology
    • 1.3.4 Molecular Imaging Technologies
    • 1.3.5 Omics Technologies
  • 1.4 Market by Application
    • 1.4.1 Global Medical In-Vitro Toxicology Testing Market Share by Application: 2020 VS 2026
    • 1.4.2 Pharmaceutical Industry
    • 1.4.3 Chemical Industry
    • 1.4.4 Food Industry
    • 1.4.5 Others
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Global Growth Trends

  • 2.1 Global Medical In-Vitro Toxicology Testing Market Perspective (2015-2026)
  • 2.2 Medical In-Vitro Toxicology Testing Growth Trends by Regions
    • 2.2.1 Medical In-Vitro Toxicology Testing Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Medical In-Vitro Toxicology Testing Historic Market Share by Regions (2015-2020)
    • 2.2.3 Medical In-Vitro Toxicology Testing Forecasted Market Size by Regions (2021-2026)
  • 2.3 Medical In-Vitro Toxicology Testing Industry Dynamic
    • 2.3.1 Medical In-Vitro Toxicology Testing Market Trends
    • 2.3.2 Medical In-Vitro Toxicology Testing Market Drivers
    • 2.3.3 Medical In-Vitro Toxicology Testing Market Challenges
    • 2.3.4 Medical In-Vitro Toxicology Testing Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Medical In-Vitro Toxicology Testing Players by Market Size
    • 3.1.1 Global Top Medical In-Vitro Toxicology Testing Players by Revenue (2015-2020)
    • 3.1.2 Global Medical In-Vitro Toxicology Testing Revenue Market Share by Players (2015-2020)
  • 3.2 Global Medical In-Vitro Toxicology Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Medical In-Vitro Toxicology Testing Revenue
  • 3.4 Global Medical In-Vitro Toxicology Testing Market Concentration Ratio
    • 3.4.1 Global Medical In-Vitro Toxicology Testing Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Medical In-Vitro Toxicology Testing Revenue in 2019
  • 3.5 Key Players Medical In-Vitro Toxicology Testing Area Served
  • 3.6 Key Players Medical In-Vitro Toxicology Testing Product Solution and Service
  • 3.7 Date of Enter into Medical In-Vitro Toxicology Testing Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Medical In-Vitro Toxicology Testing Breakdown Data by Type

  • 4.1 Global Medical In-Vitro Toxicology Testing Historic Market Size by Type (2015-2020)
  • 4.2 Global Medical In-Vitro Toxicology Testing Forecasted Market Size by Type (2021-2026)

5 Medical In-Vitro Toxicology Testing Breakdown Data by Application

  • 5.1 Global Medical In-Vitro Toxicology Testing Historic Market Size by Application (2015-2020)
  • 5.2 Global Medical In-Vitro Toxicology Testing Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Medical In-Vitro Toxicology Testing Market Size (2015-2026)
  • 6.2 North America Medical In-Vitro Toxicology Testing Market Size by Type (2015-2020)
  • 6.3 North America Medical In-Vitro Toxicology Testing Market Size by Application (2015-2020)
  • 6.4 North America Medical In-Vitro Toxicology Testing Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Medical In-Vitro Toxicology Testing Market Size (2015-2026)
  • 7.2 Europe Medical In-Vitro Toxicology Testing Market Size by Type (2015-2020)
  • 7.3 Europe Medical In-Vitro Toxicology Testing Market Size by Application (2015-2020)
  • 7.4 Europe Medical In-Vitro Toxicology Testing Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Medical In-Vitro Toxicology Testing Market Size (2015-2026)
  • 8.2 Asia-Pacific Medical In-Vitro Toxicology Testing Market Size by Type (2015-2020)
  • 8.3 Asia-Pacific Medical In-Vitro Toxicology Testing Market Size by Application (2015-2020)
  • 8.4 Asia-Pacific Medical In-Vitro Toxicology Testing Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia

9 Latin America

  • 9.1 Latin America Medical In-Vitro Toxicology Testing Market Size (2015-2026)
  • 9.2 Latin America Medical In-Vitro Toxicology Testing Market Size by Type (2015-2020)
  • 9.3 Latin America Medical In-Vitro Toxicology Testing Market Size by Application (2015-2020)
  • 9.4 Latin America Medical In-Vitro Toxicology Testing Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Medical In-Vitro Toxicology Testing Market Size (2015-2026)
  • 10.2 Middle East & Africa Medical In-Vitro Toxicology Testing Market Size by Type (2015-2020)
  • 10.3 Middle East & Africa Medical In-Vitro Toxicology Testing Market Size by Application (2015-2020)
  • 10.4 Middle East & Africa Medical In-Vitro Toxicology Testing Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE

11Key Players Profiles

  • 11.1 Covance
    • 11.1.1 Covance Company Details
    • 11.1.2 Covance Business Overview
    • 11.1.3 Covance Medical In-Vitro Toxicology Testing Introduction
    • 11.1.4 Covance Revenue in Medical In-Vitro Toxicology Testing Business (2015-2020))
    • 11.1.5 Covance Recent Development
  • 11.2 Bio-Rad Laboratories
    • 11.2.1 Bio-Rad Laboratories Company Details
    • 11.2.2 Bio-Rad Laboratories Business Overview
    • 11.2.3 Bio-Rad Laboratories Medical In-Vitro Toxicology Testing Introduction
    • 11.2.4 Bio-Rad Laboratories Revenue in Medical In-Vitro Toxicology Testing Business (2015-2020)
    • 11.2.5 Bio-Rad Laboratories Recent Development
  • 11.3 QIAGEN
    • 11.3.1 QIAGEN Company Details
    • 11.3.2 QIAGEN Business Overview
    • 11.3.3 QIAGEN Medical In-Vitro Toxicology Testing Introduction
    • 11.3.4 QIAGEN Revenue in Medical In-Vitro Toxicology Testing Business (2015-2020)
    • 11.3.5 QIAGEN Recent Development
  • 11.4 Merck
    • 11.4.1 Merck Company Details
    • 11.4.2 Merck Business Overview
    • 11.4.3 Merck Medical In-Vitro Toxicology Testing Introduction
    • 11.4.4 Merck Revenue in Medical In-Vitro Toxicology Testing Business (2015-2020)
    • 11.4.5 Merck Recent Development
  • 11.5 Thermo Fisher Scientific
    • 11.5.1 Thermo Fisher Scientific Company Details
    • 11.5.2 Thermo Fisher Scientific Business Overview
    • 11.5.3 Thermo Fisher Scientific Medical In-Vitro Toxicology Testing Introduction
    • 11.5.4 Thermo Fisher Scientific Revenue in Medical In-Vitro Toxicology Testing Business (2015-2020)
    • 11.5.5 Thermo Fisher Scientific Recent Development
  • 11.6 Charles River Laboratories
    • 11.6.1 Charles River Laboratories Company Details
    • 11.6.2 Charles River Laboratories Business Overview
    • 11.6.3 Charles River Laboratories Medical In-Vitro Toxicology Testing Introduction
    • 11.6.4 Charles River Laboratories Revenue in Medical In-Vitro Toxicology Testing Business (2015-2020)
    • 11.6.5 Charles River Laboratories Recent Development
  • 11.7 Catalent
    • 11.7.1 Catalent Company Details
    • 11.7.2 Catalent Business Overview
    • 11.7.3 Catalent Medical In-Vitro Toxicology Testing Introduction
    • 11.7.4 Catalent Revenue in Medical In-Vitro Toxicology Testing Business (2015-2020)
    • 11.7.5 Catalent Recent Development

12Analyst's Viewpoints/Conclusions

    13Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Medical In-Vitro Toxicology Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Medical In-Vitro Toxicology Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    Cell Culture Technology
    High Throughput Technology
    Molecular Imaging Technologies
    Omics Technologies

    Market segment by Application, split into
    Pharmaceutical Industry
    Chemical Industry
    Food Industry
    Others

    Based on regional and country-level analysis, the Medical In-Vitro Toxicology Testing market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    In the competitive analysis section of the report, leading as well as prominent players of the global Medical In-Vitro Toxicology Testing market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    Covance
    Bio-Rad Laboratories
    QIAGEN
    Merck
    Thermo Fisher Scientific
    Charles River Laboratories

    Buy now